Form 4: Director Sells BGMS Shares Under 10b5-1 Plan

A director and 10% owner of Bio Green Med Solution, Inc. sold 51,400 shares of common stock for $5.258 per share under a pre-arranged trading plan.

Summary

• FITTERS Diversified Berhad, identified as both a Director and a 10% Owner of Bio Green Med Solution, Inc. (BGMS), reported a transaction involving the company's common stock.
• On October 10, 2025, 51,400 shares of BGMS common stock were disposed of.
• The shares were sold at a price of $5.258 per share.
• Following this transaction, FITTERS Diversified Berhad directly beneficially owns 505,758 shares of common stock.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 4

Explanation: The sale of shares by a director and 10% owner is generally viewed as a negative signal, though the execution under a Rule 10b5-1 plan mitigates immediate panic by indicating it was pre-scheduled and not a reaction to new negative information.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to immediate market conditions or new negative information.

Negatives

• A director and significant shareholder sold a notable number of shares, which could be perceived negatively by the market, potentially signaling a lack of confidence.

Risks

• Insider selling, even if pre-planned, can sometimes be interpreted by investors as a lack of confidence in the company's future prospects, potentially leading to negative market sentiment.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• FITTERS Diversified Berhad, a director and 10% owner of Bio Green Med Solution, Inc., sold 51,400 shares of the company's common stock.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a negative signal, potentially impacting investor confidence and the company's share price.

Key Dates

Recommendation

The sale by a director and 10% owner is a notable event. However, the transaction was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not necessarily a reaction to new adverse information. Investors should monitor future insider activity and company performance, but an immediate 'sell' might be an overreaction given the pre-planned nature. A 'hold' allows for further assessment.

Keywords

Bio Green Med Solution, BGMS, FITTERS Diversified Berhad, Insider Sale, Form 4, Director Transaction, 10b5-1 Plan, Equity Sale